Infections due to gram-negative bacteria: an overview.

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Gram-negative bacterial infections are a significant challenge in hospitalized patients.
• Increasing prevalence of infections caused by Pseudomonas aeruginosa and Enterobacteriaceae, often resistant to conventional therapies.
• Common infections include malignant necrotizing otitis, sinusitis, bacteremia, skin structure infections, and osteomyelitis.

Purpose of the Study:

• To highlight the challenges in treating gram-negative bacterial infections in hospitalized patients.
• To introduce aztreonam as a potential alternative therapeutic agent.
• To emphasize the need for further evaluation of aztreonam's efficacy.

Main Methods:

• Review of clinical cases and treatment outcomes for gram-negative infections.
• Analysis of pathogen prevalence, including Pseudomonas aeruginosa and resistant Enterobacteriaceae.
• Evaluation of therapeutic strategies, focusing on the role of aminoglycosides and aztreonam.

Main Results:

• Gram-negative bacteria, particularly P. aeruginosa and resistant Enterobacteriaceae, are major pathogens in various hospital-acquired infections.
• Aminoglycosides have been a mainstay therapy, but high mortality persists.
• Aztreonam demonstrates activity against aerobic gram-negative bacilli and presents a successful alternative approach.

Conclusions:

• Gram-negative bacterial infections remain a critical concern in healthcare settings.
• The emergence of multidrug-resistant organisms necessitates novel therapeutic options.
• Aztreonam shows promise as an effective treatment for aerobic gram-negative bacillary infections and warrants further investigation.